ArticleFrontiers in public health2024
Female and male treatable mortality: socioeconomic and public finance related factors across European countries.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: About 36.5% of premature deaths in European Union countries could have been avoided through prompt and effective medical treatment. This treatable mortality is even a priority established in Sustainable Development Goal (SDG) target 3.4. Given the gap in the literature about the socioeconomic drivers of this type of mortality, as well as the increasing importance of public financial management in defining priority policies, this study aims to analyze the socioeconomic and public finance drivers associated with treatable mortality for women and men across European countries. Methods: Eurostat data is collected for 31 countries for the period 2011-2019 stratified by sex. Panel data quantile regression with fixed effects and conditional mean panel data model using feasible generalized least squares are estimated to explain treatable mortality in women and men. Results: Key findings point to a positive association between the public finance indicator proxying health priority and the treatable mortality rate for both sexes; a difference between drivers of treatable mortality between men and women; and a different set of drivers across the different quantiles of treatable mortality. Conclusion: Drivers of male and female treatable mortality may differ according to the country's level of mortality rate. Government health priority seems to account for previous treatable mortality rates as a reactive measure. Policymakers aiming to reduce treatable mortality are likely to use instruments such as health expenditure, improved employment, education levels, and perhaps proactive policy-setting priorities concerning health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.